SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-026431
Filing Date
2024-11-08
Accepted
2024-11-08 16:20:13
Documents
1
Period of Report
2024-11-06

Document Format Files

Seq Description Document Type Size
1 form4-11082024_041109.html 4  
1 form4-11082024_041109.xml 4 3383
  Complete submission text file 0001415889-24-026431.txt   4877
Mailing Address 100 CAMBRIDGEPARK DRIVE SUITE 101 CAMBRIDGE MA 02140
Business Address 100 CAMBRIDGEPARK DRIVE SUITE 101 CAMBRIDGE MA 02140 617-655-6580
Vor Biopharma Inc. (Issuer) CIK: 0001817229 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O VOR BIOPHARMA INC. 100 CAMBRIDGEPARK DRIVE, SUITE 400 CAMBRIDGE MA 02140
Business Address
Chakraborty Tirtha (Reporting) CIK: 0001840685 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39979 | Film No.: 241440906